Quantum Biopharma (QNTM) Intangibles (2019 - 2026)

Quantum Biopharma has disclosed Intangibles across 8 years of filings, most recently posting $4.4 million for Q1 2026.

• Intangibles for Q1 2026 came in at $4.4 million, down 8.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.4 million (down 8.71% YoY), and the FY2025 annual result was $4.5 million, down 8.53% from the prior year.
• Intangibles came in at $4.4 million for Q1 2026 at Quantum Biopharma, down from $4.5 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $15.4 million in Q1 2022 to a low of $4.4 million in Q1 2026.
• The 5-year median for Intangibles is $5.1 million (2024), against an average of $7.6 million.
• Across the five-year window, Intangibles gained 19.01% in 2022 and tumbled 60.98% in 2023, its largest moves.
• Quantum Biopharma's Intangibles stood at $12.0 million in 2022, then slumped by 54.64% to $5.5 million in 2023, then slipped by 9.66% to $4.9 million in 2024, then declined by 8.53% to $4.5 million in 2025, then dropped by 2.3% to $4.4 million in 2026.
• The last three Intangibles figures came in at $4.4 million (Q1 2026), $4.5 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.